Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 9/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8779862 | 0.82 | ITGB2 (0.50) | CCR2HPGDALDH1A1HSD17B10MEN1 | |
| SCHEMBL1145559 | 0.82 | TP53 (0.48) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL18850253 | 0.80 | CCR2 (0.46) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL31396637 | 0.80 | CCR2 (0.44) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL8492853 | 0.80 | CYP3A4 (0.48) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL8489299 | 0.80 | CCR2 (0.44) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL110557 | 0.78 | ALDH1A1 (0.52) | CCR2HPGDALDH1A1ALOX15HSD17B10 | |
| SCHEMBL16954941 | 0.78 | CCR2 (0.42) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL3783594 | 0.78 | CYP3A4 (0.52) | CCR2HPGDALDH1A1HTTALOX15 | |
| SCHEMBL20734681 | 0.78 | CCR2 (0.53) | CCR2HPGDALDH1A1HTTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
| US-4786739-A | SULFIDING | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 1988-11-22 | — | — | US | disclosed |
| EP-0146610-A4 | SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES. | DU PONT (US) | 1986-02-20 | — | — | EP | disclosed |
| US-4571404-A | PLANT HERBICIDE, FUNGICIDE OR VIRICIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-02-18 | — | — | US | disclosed |
| EP-0146610-A1 | SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-07-03 | — | — | EP | disclosed |
| WO-1984004921-A1 | SUBSTITUTED BENZOPENTATHIEPINS, PROCESS THEREFOR AND INTERMEDIATES | DU PONT (US) | 1984-12-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | CCR2 2329/4885HPGD 2790/4885ALDH1A1 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.